Skip to main content

Neurology

RSS  

Articles

  • ABCD2 Score as a Predictor of Three-Year Stroke Risk

    This retrospective cohort study using the National Patient Registry in Denmark analyzed a three-year follow-up period following a transient ischemic attack, looking at the rate of recurrent stroke and mortality. The patients were divided into low risk (ABCD2 score 0-3) and high risk (ABCD2 score ≥ 4). The stroke rate was 6% in the high-risk group and 4% in the low-risk group.

  • Clinical, Biological, and Imaging Features of Intravascular Large B-Cell Lymphoma

    A multicenter, retrospective cohort study of 17 patients with pathology-proven intravascular lymphoma involving the central nervous system identified “red flag” clinical features, imaging patterns, and cerebrospinal fluid characteristics that may help expedite the diagnosis of this rare, complex, and deceptive disease.

  • ABCD2 Score as a Predictor of Three-Year Stroke Risk

    This retrospective cohort study using the National Patient Registry in Denmark analyzed a three-year follow-up period following a transient ischemic attack, looking at the rate of recurrent stroke and mortality. The patients were divided into low risk (ABCD2 score 0-3) and high risk (ABCD2 score ≥ 4). The stroke rate was 6% in the high-risk group and 4% in the low-risk group.

  • Modifiable Cardiovascular Risk Factors and Late-Life Brain Health

    The major modifiable risk factors for cardiovascular diseases are delineated in Life’s Essential 8 (LE8), developed by the American Heart Association. These risk factors are blood pressure, glucose, cholesterol, body mass index, smoking, physical activity, diet, and sleep duration. The investigators in this analysis of two large databases in the United Kingdom and the United States, demonstrated that cardiovascular health, as defined by the LE8, will also predict brain health later in life.

  • Migraine and Ischemic Vascular Disease: The Search for the Missing Link

    The presence of traditional vascular risk factors does not explain the increased incidence of ischemic stroke and myocardial infarction in patients with migraine. The use of nonsteroidal anti-inflammatory drugs does not increase the risk of ischemic stroke or myocardial infarction in migraineurs.

  • Intravenous Tenecteplase for Stroke After 4.5 Hours Does Not Improve Outcome

    Standard therapy for acute ischemic stroke is intravenous thrombolysis within 4.5 hours from onset of symptoms. Alteplase has been the standard medication, but in recent years, tenecteplase has supplanted alteplase because of its ease of administration as a single intravenous bolus and lower cost.

  • Post-Traumatic Epilepsy and the Risk of Dementia

    A subset of people with head injury will develop post-traumatic epilepsy (PTE). This prospective cohort study demonstrated a 4.5-fold increased risk of dementia in those with PTE compared to people without head trauma or epilepsy, and that this risk exceeds that observed in people with head trauma or epilepsy alone.

  • Wildfire Smoke Exposure Is a Risk Factor for Dementia

    In this large, open cohort study based on electronic health record data from 2009 to 2019 of dementia-free people older than 60 years of age, exposure to wildfire smoke resulted in an increased incidence of dementia later in life.

  • Psychiatric Comorbidities in Persons with Epilepsy

    In this systematic review and meta-analysis, the prevalence of most psychiatric disorders was significantly higher in persons with epilepsy than in those without epilepsy. These findings show the high burden of psychiatric comorbidities in persons with epilepsy and underscore the importance of appropriately identifying and treating psychiatric comorbidities in epilepsy patients.

  • Patterns of Brain Atrophy in Memory Disorders

    In this multicenter, memory clinic-based cohort targeting earliest at-risk states for dementia of Alzheimer’s type, limbic-predominant and hippocampus-sparing atrophy subtypes were identified. Limbic-predominant atrophy was linked to worse cognitive outcomes over time, including in individuals who were asymptomatic or only had subjective memory symptoms at the time of baseline imaging.